Sigma-Aldrich (Nasdaq: SIAL) Reports 18.5% Gain in Q3 2008 Diluted EPS and Reaffirms Full Year 2008 Diluted EPS Forecast. Q3 2008 Sales Increase 7.4%. Buyback Authorization Increased by 10 Million Shares.
... Research and Fine Chemicals. Currency could add
another 3% to 4% to full year 2008 sales ... very well. And,
we're now finalizing our plans to add
new activities as we seek to drive
growth above ... nine months of 2008. Currency benefits could add
to 4% to full year organic growth, but reduce ...
Sigma-Aldrich (Nasdaq: SIAL) Reports 16.7% Gain in Q2 2008 Diluted EPS. Q2 2008 Sales Rise 14.4%. 2008 Diluted EPS Forecast Raised $.05 to $2.62-$2.72.
... organic growth goal. Currency benefits could add
another 6% to growth if currency exchange ... products. Our short-term actions to add
innovative new products
across the drug discovery ... growth goal for 2008. Currency
benefits could add
6% to this organic growth if currency exchange ...
Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%.
... organic growth goal. Currency benefits could add
another 6% to growth, a three percentage ... of new
products as part of a program to add
new cell culture products during 2008
and efforts ... growth goal for 2008. Currency
benefits could add
6% to this organic growth if currency exchange ...
QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes (As Revised)
... ) Ligand Pharmaceuticals, Inc. (Nasdaq: LGND ) add
Fornix Biosciences N.V. (Amsterdam: FORBI.AS) ... Index (HHK) Drop Shire PLC (Nasdaq: SHPGY ) add
Ark Therapeutics Group Plc (LSE: AKT.L)
Cardio ... Drop Biosphere Medical, Inc. (Nasdaq: BSMD ) add
Zoll Medical Corp. (Nasdaq: ZOLL )
Sigma-Aldrich (Nasdaq: SIAL) Annual Sales Surpass $2 Billion Mark.
... acquisition is expected. Currency benefits could add
another 3% to growth if currency exchange ... on an ongoing basis, some of which may well add
to our future revenue base."
Nagarkatti ... 2007 acquisition
and currency benefits could add
3% more to reported growth rates if
Sigma-Aldrich (Nasdaq: SIAL) Q3 2007 Sales Increase 14.0%, Yielding Diluted EPS of $.54.
... The acquisition of Epichem is expected to add
an additional 2% in growth for the full year. Currency benefits could add
more than 4% to these growth estimates if ... organic
sales growth at our targeted 7% level and add
another 3% from acquisitions.
And, we expect ...
ThermoGenesis Provides Update on Fiscal 2009 Results
Positive clinical response to the MXP. The Company intends to add
additional MXP distribution partners in fiscal 2010.
Launch of the Res-Q System. Res-Q is expected to add
incremental revenues in 2010 through its expanded distribution agreement ...
SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights
... associated with tumor initiation and progression. The company expects to add
more oncogenes and mutations to the OncoCarta panel in the near future.
... the Company's current plans to introduce a series of diagnostic tests, to add
enhancements to the OncoCarta panel and to commercialize the AttoSense HPV ...
BioNeutral's Ygiene(TM) Hospital Grade Achieves a 100% Total Kill (Pass) Against the Life Threatening Clostridium Difficile (C.diff) Spores in Independent EPA Required Protocol Testing.
... BioNeutral Group CEO Stephen J. Browand commented, "There is little I can add
that will enhance anyone's understanding of a perfect independent test ... firmly on their own accord and what is now public record. I will only add
that the creation of our Ygiene(TM) formula by Dr. Kielbania and his ...
Exiqon Diagnostics Partners With MedTrust Online to Promote KRAS Mutation Analysis and Other Innovative Molecular Oncology Diagnostic Services to Oncologists
... MedTrust Online's Oncocentric oncology portal.
MedTrust Online will add
Exiqon Diagnostics service offerings, extensive clinical studies, ... well as pathologists and support staff nationwide.
"We are pleased to add
Exiqon Diagnostics to the growing list of molecular diagnostic companies ...
SpectraScience Secures Distribution for WavSTAT(R) Cancer Diagnosis System in Germany & Austria
... SpectraScience's VP Sales and Marketing, commented, "We are pleased to add
another distribution partner in Europe. Krainer Medtechnik is a respected and well-established medical distribution company and its decision to add
the WavSTAT Optical Biopsy System to their portfolio is a strong ...
Shire begins the year with a strong performance
... a tax deduction on its convertible bond
interest, and the interest add
back for 2009 represents gross interest
expense. The Company expects the full year add
back to be approximately $34
(2) Excludes shares purchased ...
Mach One CEO Letter to Shareholders
... products are our initial, primary focus, we intend in the near future to add
Nutraceuticals to our growing list of ventures. In the process, we intend ... products are our initial primary focus, we intend in the near future to add
Nutraceuticals to our growing list of operating groups. As an ongoing ...
Frost & Sullivan Recognizes Nanopoint for its Pioneering Cell Imaging Solution, the cellTRAY(R) Imaging System CT-2000
"The cellTRAY Imaging CT-2000 system has the potential to add
value to the diagnostic testing services industry because of its ... of its development of the cellTRAY(R) Imaging CT-2000 system and value add
to the diagnostic testing services industry, Frost & Sullivan is proud ...
SAFC Pharma Augments Assay Development Capabilities
... suites. Due to be operational before 2009 year end, these suites will add
an additional 8,000 sq. ft. of manufacturing space and enable 100 liter ... liter batch manufacturing in disposable bioreactors. The expansion will add
commercial manufacturing capacity within the current 44,000 sq. ft. site ...
Highlights of Economic and Business Growth in the Tampa Bay Region (News Briefs)
... and consumers, is planning to move its manufacturing to Manatee
County and add
up to 24 employees in 2009. Quasar Bio-Tech relocated its
headquarters, ... Machine currently employs 17 full-time workers and expects to add
additional 10 employees with their expansion. Construction has begun on ...
Atherotech to Exhibit VAP(R) Cholesterol Test at American Heart Association Scientific Sessions 2008
... Atherotech to add
new apoA1 measurement and apoB:apoA1 ratio to its
comprehensive ... and apoB as part of its standard test. Atherotech has
announced plans to add
apolipoprotein A-1 (apoA1) to its reporting in early
2009. ApoA1 is the ...
Inverness Medical Innovations Announces Third Quarter 2008 Results
... ended September 30, 2008, on an adjusted cash basis, includes the add
back of interest expense related to the convertible debt of $0.7 ... ended September 30, 2008, on an adjusted cash basis, includes the add
back of interest expense related to the convertible debt of $2.1 ...
Five New Clinical Studies Show Value of Masimo PVI & PI
... O'Reilly, MD, EVP of Medical Affairs at Masimo, stated; "These
to the evidence showing that PVI can provide clinicians with an
effective ... more accurate fluid
administration decisions -- allowing clinicians to add
a level of certainty
and immediacy toward managing intravascular fluid ...
First tunable, 'noiseless' amplifier may boost quantum computing, communications
... quantum computing and communications systems.
Conventional amplifiers add
unwanted noise, or random fluctuations, when they measure and boost electromagnetic signals. Amplifiers that theoretically add
no noise have been demonstrated before, but the JILA/NIST technology, ...
Ondine Biopharma Announces Second Quarter 2008 Financial Results
... the sale of its products through additional
distributors in Canada will add
to the installed base of its Periowave(TM)
PDD systems in Canada as the ... Loss for the period (2,432,217) (3,789,406) (4,895,219) (7,241,652) add
items not affecting cash: Depreciation and amortization ...
Isis Reports Financial Results and Highlights for Second Quarter of 2008
... as our corporate alliances continue to be
successful, we will continue to add
cash to our balance sheet and revenue
to our P&L. We remain on track to ... remaining equity by June 30, 2009 -- Extended government contracts that add
to Ibis' revenue and fund the expansion of applications of the Ibis ...
Inverness Medical Innovations Announces Second Quarter 2008 Results
... three months ended June 30, 2008, on an adjusted cash basis, includes the add
back of interest expense related to the convertible debt of $0.8 million ... six months ended June 30, 2008, on an adjusted cash basis, includes the add
back of interest expense related to the convertible debt of $1.5 million ...
CSC and HealthTrio Team to Offer Portal and Personal Health Record Solution
... CSC (NYSE: CSC ) today
announced that it will team with HealthTrio LLC to add
portal and personal
health record (PHR) solutions to CSC's FirstPortfolio ... best-in-class product
FirstPortfolio allows health plans to add
new functionality in a
fraction of the time required for traditional ...
Highlights of Economic and Business Growth in the Tampa Bay Region
... With Mexico, South America
In late July, Peruvian Amazon Line plans to add
cargo service every 60
days between the Port of Tampa and Houston; ... County to expand with a new branch of operations. The expansion
30 new jobs over three years, each paying 200% of the average
annual wage ...
Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance
... million diluted Class A common shares outstanding. In
calculating CNI, we add
back the after-tax impact of the amortization of
intangible assets and the ... a summary to show the
computation of CNI and adjusted cash net income to add
non-cash and one-time or nonrecurring charges. The Company ...
Ocular Biopharmaceutical Company Charlesson Announces $1.6MM in New Funding and Upcoming Presentations at The Association for Research in Vision and Ophthalmology
... services for AMD drug development. We are excited at the potential
this unique and powerful model to Charlesson's preclinical ... Pfizer Global Research and Development in Connecticut.
"We are excited to add
Dr. Analoui to our team at Charlesson. His wealth of
expertise in drug ...
Governor Patrick Announces Life Sciences Initiative Victory With Organogenesis' New Headquarters
... the company's decision to remain and expand in
Massachusetts and thereby add
hundreds of highly skilled jobs.
"I am pleased that Organogenesis will ... remaining space is empty open bay for expansion) -- Upgrades may add
up to 10,500 square feet to the building footprint
150 Dan Road -- To ...
Aida Pharmaceuticals, Inc. Acquires High-Level Research Institute in the People's Republic of China
... Acquisition Expected to add
New Drug Products to Aida Pharmaceuticals, Inc.'s ... subsidiary of Aida Pharmaceuticals. This
acquisition is expected to add
several new products to Aida
Pharmaceutical's existing line of products, ...
FDA Approves PRISTIQ(TM) for the Treatment of Adult Patients with Major Depressive Disorder
... use of aspirin, NSAIDs, warfarin, and other anticoagulants may add
to this risk. -- Mydriasis has been reported in association with PRISTIQ; ... use of aspirin, NSAIDs, warfarin, and other anticoagulants may add
to this risk. -- Mydriasis has been reported in association with ...
US Oncology Reports Fourth Quarter and Fiscal Year 2007 Results
... Holdings Net Loss $(14,830) $(34,973)
back: General and administrative expense (21) 97 ... Net income (loss) $(14,830) $3,253 $(4,194) $(34,973) $26,158 add
back: Interest expense, net 36,913 29,547 ...
United Therapeutics Reports Fourth Quarter and Annual 2007 Financial Results
... Net income, as reported $15,449 $65,016 $73,965 $19,859 add
(subtract) back: Interest expense 4 29 ... 2006
Net income, as reported $1,986 $55,508 add
(subtract) back: Interest expense 34 481 ...
MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study
... MGIFF), a clinical-stage developer of drugs for infectious
diseases, will add
a 600mg celgosivir combination therapy arm to its
currently enrolling ... step for the optimization and advancement of
celgosivir; our plans to add
approximately six patients at 600mg dose in
the celgosivir Phase II viral ...
SAFC Pharma to Increase Viral Product Manufacturing Capacity
... Due to become operational in the second half of 2009, the new suites
8,000 sq. ft. of manufacturing space and enable 100 L batch
production in ... 1,000 L batch manufacturing in
disposable bioreactors. The expansion will add
to the current 44,000 sq.
ft. site and be Biosafety Level 2 compliant, ...
Raptor Pharmaceuticals Acquires Orphan Clinical Program
... as Batten disease and Huntington's disease.
"EC Cysteamine will add
value, and balance our clinical portfolio with
an advanced clinical ... metabolic and
neurodegenerative diseases; the ability of EC Cysteamine to add
balance to our clinical portfolio; the Company's ability to ...
Siemens Expands the SOMATOM Definition(TM) Line With World's First Adaptive CT Scanner
... area with a 200-cm
scan range, 78-cm gantry bore and the ability to add
a high-capacity 650-lb
patient table. These features allow even the most ... not
possible with single-source scanners. Siemens will continue to add
dual- energy applications to its six FDA approved syngo(R) Dual ...
Schering-Plough Completes Acquisition of Organon BioSciences
... and central nervous system (CNS)," added Hassan.
"These therapeutic areas add
to our existing strengths in cardiovascular
care, respiratory, immunology ... a muscle relaxant; and NUVARING and IMPLANON
for contraception. These add
to Schering-Plough's strong base of human
pharmaceuticals, including ...
United Therapeutics Reports Third Quarter 2007 Financial Results
... Net income, as reported $ 17,873 $ 18,458 add
back: Impairment of HeartBar tradename - ... Net income, as reported $ 14,848 $ 8,478 add
back: Interest expense 717 ...
Oncologists Want to See Significant Improvement in Overall Survival Before Adopting Targeted Polytherapy in a First-Line Setting
... were asked what the minimum
benefit is that would persuade them to add
Squibb/Merck KGaA's Erbitux to Genentech/Roche's ... would require a significant improvement in overall survival in
order to add
Erbitux to Avastin and chemotherapy. On average, oncologists
require 24 ...
Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
... in gene discovery and validation. "At Dow AgroSciences we continue to add
cutting-edge tools to our
Research and Development portfolio, and are excited about what this
agreement will enable us to add
to our existing capabilities," said Daniel
R. Kittle, Ph.D., vice ...